<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03740386</url>
  </required_header>
  <id_info>
    <org_study_id>LeonFormacion</org_study_id>
    <nct_id>NCT03740386</nct_id>
  </id_info>
  <brief_title>Phentolamine Mesylate as a Reversal of Local Anesthesics</brief_title>
  <official_title>Phentolamine Mesylate as a Reversal of Local Anesthesics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>León Formación</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>León Formación</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oraverse © (Phentolamine mesylate) is a product designed to reverse the effect of local
      anesthetics used in dentistry. Its main objective is to reduce the postoperative period
      during which the patient suffers from the lack of sensitivity in the perioral soft tissues,
      it is an obvious discomfort, a difficulty to speak or eat, and sometimes a risk of
      self-injury in the lips and / or tongue .

      The product was approved by the FDA in 2008 although the introduction in Spain has not
      occurred until December 2015. There are numerous studies that support its use, its
      effectiveness and safety, although none of the Spanish population, who have not yet had the
      opportunity to experience it.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PURPOSE OF THE STUDY:

      To analyze the response of Oraverse in patients receiving complete oral disinfection
      treatment, after administration of Lidocaine 2% 1/80000, Articaine 4% 1/200000 or Bupivacaine
      0,5% 1:200000 in mandible, in comparison with the contralateral control side.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">November 9, 2018</completion_date>
  <primary_completion_date type="Actual">November 9, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Three randomized groups</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>We use a program to randomize three groups. Double blind study No sham or placebo</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>time lip recovery fron local anesthesia</measure>
    <time_frame>1 day</time_frame>
    <description>self reported lip sensitivity by questionaire marking every 15 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post intervention pain</measure>
    <time_frame>1 day</time_frame>
    <description>visual analogue scale to measure pain: Line ranged from 1 to 10 units where 1 means no pain at all and 10 means the worst imaginable pain. Lower levels are good outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post intervention bleeding</measure>
    <time_frame>1 day</time_frame>
    <description>clinical assesment of post intervention bleeding when using phentolamine mesylate</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lidocaine 2% 1:80000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>articaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>articaine 4% 1:200000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bupivacaine 0,5% 1:200000</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phentolamine Mesylate 0.235 MG/ML [OraVerse]</intervention_name>
    <description>compare effect of phentolamine mesylate in three arms</description>
    <arm_group_label>articaine</arm_group_label>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_label>lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previously diagnosticated to receive dental treatment according to Leonformacion's
             criteria

        Exclusion Criteria:

          -  Hepatic or renal patient

          -  Fertility treatment, pregnancy or lactation

          -  Treatment with oral anticoagulants

          -  Patients with known allergies to anesthetics, excipients or phentolamine mesylate

          -  Patients with previous facial paresthesia

          -  Patients who had taken any painkiller or anti-inflammatory the day before

          -  Patients in which the anesthetic technique fails or has to be reinforced with more
             than two carpules
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Prados-Frutos JC, Rojo R, González-Serrano J, González-Serrano C, Sammartino G, Martínez-González JM, Sánchez-Monescillo A. Phentolamine mesylate to reverse oral soft-tissue local anesthesia: A systematic review and meta-analysis. J Am Dent Assoc. 2015 Oct;146(10):751-9.e3. doi: 10.1016/j.adaj.2015.04.018. Review.</citation>
    <PMID>26409985</PMID>
  </results_reference>
  <results_reference>
    <citation>Hersh EV, Moore PA, Papas AS, Goodson JM, Navalta LA, Rogy S, Rutherford B, Yagiela JA; Soft Tissue Anesthesia Recovery Group. Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adults. J Am Dent Assoc. 2008 Aug;139(8):1080-93.</citation>
    <PMID>18682623</PMID>
  </results_reference>
  <results_reference>
    <citation>Laviola M, McGavin SK, Freer GA, Plancich G, Woodbury SC, Marinkovich S, Morrison R, Reader A, Rutherford RB, Yagiela JA. Randomized study of phentolamine mesylate for reversal of local anesthesia. J Dent Res. 2008 Jul;87(7):635-9.</citation>
    <PMID>18573982</PMID>
  </results_reference>
  <results_reference>
    <citation>Fowler S, Nusstein J, Drum M, Reader A, Beck M. Reversal of soft-tissue anesthesia in asymptomatic endodontic patients: a preliminary, prospective, randomized, single-blind study. J Endod. 2011 Oct;37(10):1353-8. doi: 10.1016/j.joen.2011.06.019. Epub 2011 Aug 5.</citation>
    <PMID>21924181</PMID>
  </results_reference>
  <results_reference>
    <citation>Tavares M, Goodson JM, Studen-Pavlovich D, Yagiela JA, Navalta LA, Rogy S, Rutherford B, Gordon S, Papas AS; Soft Tissue Anesthesia Reversal Group. Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patients. J Am Dent Assoc. 2008 Aug;139(8):1095-104. Erratum in: J Am Dent Assoc. 2008 Oct;139(10):1312.</citation>
    <PMID>18682624</PMID>
  </results_reference>
  <results_reference>
    <citation>Moore PA, Hersh EV, Papas AS, Goodson JM, Yagiela JA, Rutherford B, Rogy S, Navalta L. Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylate. Anesth Prog. 2008 Summer;55(2):40-8. doi: 10.2344/0003-3006(2008)55[40:POLWEF]2.0.CO;2.</citation>
    <PMID>18547152</PMID>
  </results_reference>
  <results_reference>
    <citation>Hersh EV, Lindemeyer RG. Phentolamine mesylate for accelerating recovery from lip and tongue anesthesia. Dent Clin North Am. 2010 Oct;54(4):631-42. doi: 10.1016/j.cden.2010.06.004. Review.</citation>
    <PMID>20831927</PMID>
  </results_reference>
  <results_reference>
    <citation>Elmore S, Nusstein J, Drum M, Reader A, Beck M, Fowler S. Reversal of pulpal and soft tissue anesthesia by using phentolamine: a prospective randomized, single-blind study. J Endod. 2013 Apr;39(4):429-34. doi: 10.1016/j.joen.2012.12.024. Epub 2013 Feb 11.</citation>
    <PMID>23522530</PMID>
  </results_reference>
  <results_reference>
    <citation>Daubländer M, Liebaug F, Niedeggen G, Theobald K, Kürzinger ML. Effectiveness and safety of phentolamine mesylate in routine dental care. J Am Dent Assoc. 2017 Mar;148(3):149-156. doi: 10.1016/j.adaj.2016.11.017. Epub 2017 Jan 23.</citation>
    <PMID>28126226</PMID>
  </results_reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 9, 2018</study_first_submitted>
  <study_first_submitted_qc>November 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>November 10, 2018</last_update_submitted>
  <last_update_submitted_qc>November 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>León Formación</investigator_affiliation>
    <investigator_full_name>alejandro gago garcia</investigator_full_name>
    <investigator_title>Assintant professor</investigator_title>
  </responsible_party>
  <keyword>phentolamine mesylate</keyword>
  <keyword>reverse local anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phentolamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

